humanitarian
Medicine shortage communication (MSC): Emend (aprepitant, 80 mg hard capsules; 125 mg hard capsules; 125 mg powder for oral suspension): planned permanent marketing cessation (dis…
Medicine shortage communication (MSC): Emend (aprepitant, 80 mg hard capsules; 125 mg hard capsules; 125 mg powder for oral suspension): planned permanent marketing cessation (discontinuation)
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
EMA What Is NewMedicine shortage communication (MSC): Emend (aprepitant, 80 mg hard capsules; 125 mg hard capsules; 125 mg powder for oral suspension): planned permanent marketing cessation (dis…EMA What Is NewMedicine shortage communication (MSC): Emend (aprepitant, 80 mg hard capsules; 125 mg hard capsules; 125 mg powder for oral suspension): planned permanent marketing cessation (dis…5 recorded states
Signal first indexedP2 · 88% quality · 1 source
Corroboration 1→2 sources · quality 88→92P2 · 92% quality · 2 sources
Quality 92→96P2 · 96% quality · 2 sources
Quality 96→99P2 · 99% quality · 2 sources
Corroboration 2→1 sourcesP2 · 99% quality · 1 source